rs78517449
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_000912.5(OPRK1):c.948C>T(p.Ile316Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00356 in 1,614,192 control chromosomes in the GnomAD database, including 174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 94 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 80 hom. )
Consequence
OPRK1
NM_000912.5 synonymous
NM_000912.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.363
Publications
2 publications found
Genes affected
OPRK1 (HGNC:8154): (opioid receptor kappa 1) This gene encodes an opioid receptor, which is a member of the 7 transmembrane-spanning G protein-coupled receptor family. It functions as a receptor for endogenous ligands, as well as a receptor for various synthetic opioids. Ligand binding results in inhibition of adenylate cyclase activity and neurotransmitter release. This opioid receptor plays a role in the perception of pain and mediating the hypolocomotor, analgesic and aversive actions of synthetic opioids. Variations in this gene have also been associated with alcohol dependence and opiate addiction. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 8-53229492-G-A is Benign according to our data. Variant chr8-53229492-G-A is described in ClinVar as [Benign]. Clinvar id is 790059.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.363 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPRK1 | NM_000912.5 | c.948C>T | p.Ile316Ile | synonymous_variant | Exon 4 of 4 | ENST00000265572.8 | NP_000903.2 | |
OPRK1 | NM_001318497.2 | c.948C>T | p.Ile316Ile | synonymous_variant | Exon 4 of 4 | NP_001305426.1 | ||
OPRK1 | NM_001282904.2 | c.681C>T | p.Ile227Ile | synonymous_variant | Exon 5 of 5 | NP_001269833.1 | ||
LOC105375836 | NR_188096.1 | n.2204G>A | non_coding_transcript_exon_variant | Exon 3 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0188 AC: 2867AN: 152208Hom.: 94 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2867
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00525 AC: 1318AN: 251216 AF XY: 0.00385 show subpopulations
GnomAD2 exomes
AF:
AC:
1318
AN:
251216
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00197 AC: 2876AN: 1461866Hom.: 80 Cov.: 32 AF XY: 0.00168 AC XY: 1220AN XY: 727224 show subpopulations
GnomAD4 exome
AF:
AC:
2876
AN:
1461866
Hom.:
Cov.:
32
AF XY:
AC XY:
1220
AN XY:
727224
show subpopulations
African (AFR)
AF:
AC:
2259
AN:
33480
American (AMR)
AF:
AC:
163
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
6
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
168
AN:
1112002
Other (OTH)
AF:
AC:
262
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
181
362
544
725
906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0188 AC: 2868AN: 152326Hom.: 94 Cov.: 32 AF XY: 0.0186 AC XY: 1385AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
2868
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
1385
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
2707
AN:
41558
American (AMR)
AF:
AC:
104
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23
AN:
68038
Other (OTH)
AF:
AC:
30
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
138
275
413
550
688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.